News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC
Photo: Depositphotos
Jun 2, 2025, 09:18

Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC

Excellence in Oncology Care – EIOC posted on X:

“5 year follow up for adjuvant pembro in RCC (KN564). DFS (5yr 52% v61% – HR0.71). OS (5yr 82% vs 88% HR0.66). Maintained KM curve separation.”

Excellence in Oncology Care Shares 5-Year KN564 Data on Adjuvant Pembrolizumab in RCC

More posts featuring ASCO25.

cancer Excellence in Oncology Care OncoDaily Oncology RCC
Special Coverage
Blog Posts
Aug 26, 2025, 15:24
Belén Garijo Reflects on 1,000 Days of AI: The Journey and What’s Next
Science
Aug 26, 2025, 15:12
Nicholas P Restifo: From Hand-Crafting TILs to Robotic Manufacturing
Voices
Aug 26, 2025, 15:05
Lucy Harutyunyan Attends Thermo Fisher Scientific User Meeting at IMP
Positive
Aug 26, 2025, 14:54
Jarushka Naidoo Congratulates Dr. David O'Reilly on 2025 IASLC Fellowship Award
Immune Oncology
Aug 26, 2025, 14:37
New IO Paper Alert: CRISPR Screens Uncover New Targets to Boost CAR-NK Cell Therapy
Voices
Aug 26, 2025, 14:33
Françoise Meunier and Lidia Dyndor Discuss the Right to Be Forgotten for Cancer Survivors
Voices
Aug 26, 2025, 14:12
Sachin H. Jain Unveils SCAN Health Plan's New Consumer Advertising Campaign
Voices
Aug 26, 2025, 14:04
Toufic Kachaamy: Calling All Experts to Join the Endoscopic Oncology Committee
Voices
Aug 26, 2025, 13:55
Penilla Gunther: Inauguration of ATMP Centres at Karolinska
Oncolibrary
Aug 26, 2025, 13:52
China Approved DATROWAY (Datopotamab Deruxtecan) for HR-Positive, HER2-Negative Metastatic Breast Cancer
OncoDaily Pulse
Aug 26, 2025, 13:50
Guillermo De Velasco: Meet the Experts of VIRO 2025
Opinion
Aug 26, 2025, 13:42
Ayo O. Ayodele: I Crossed the Finish Line of My First Triathlon